July 2009
Advertisement
Advertisement
Trending on Pharmacy Times
1
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
2
FDA Approves Etuvetidigene Autotemcel, First Gene Therapy for Wiskott-Aldrich Syndrome
3
Experts Weigh In on GLP-1 Agonist Use in Pediatric Patients with Obesity
4
Automation and Standardization Take Center Stage in Health System’s Centralized IV Compounding Strategy
5
